Kemipharm
- Company typePrivate
- Founded-
- Headquarters—
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Kemipharm firmographics
Firmographics- Name
- Kemipharm
- Website
- https://kemipharm.com
- Company type
- Private
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Kemipharm business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
Kemipharm product offering
Product offeringCore offering
No description of Kemipharm's core offering can be supported by the available source data. The company's website (kemipharm.com) currently displays only a HostGator hosting-provider placeholder page rather than content describing its products or services.
Differentiator
Problem solved
Functional benefit
Kemipharm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Kemipharm competitors and assessment
Company assessmentBroad incumbents
- Aptuit (Evotec): Drug discovery and CMC development services provider with pharmaceutical chemistry capabilities, now part of Evotec. Overlaps a chemistry-led pharma services business targeting development-stage customers.
- Lonza: Global CDMO leader across small molecules, biologics, and cell & gene therapies. Relevant as a benchmark for scale and as the dominant incumbents a smaller chemistry-based manufacturer would compete against for contract volumes.
Direct peers
- Recipharm: European-headquartered pharmaceutical contract development and manufacturing organization (CDMO) offering solid-dose, sterile, and API production. Most directly relevant if Kemipharm operates as a Nordic/specialty pharma CDMO with chemistry-focused capabilities.
- Cambrex: Small-molecule API and finished-dose contract manufacturer serving branded and generic pharma customers. Comparable to a specialty intermediates manufacturer anchored in chemistry ('kemi') production.
Market position
Customer concentration
Kemipharm social profiles
Digital presenceKemipharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kemipharm leadership team
Management profileNumber of profiles
Kemipharm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kemipharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kemipharm
What does Kemipharm do?
No description of Kemipharm's core offering can be supported by the available source data. The company's website (kemipharm.com) currently displays only a HostGator hosting-provider placeholder page rather than content describing its products or services.
When was Kemipharm founded?
Kemipharm was founded in -1. It employs 11 to 50 people.
Who are Kemipharm's main competitors?
Broad incumbents on record are Aptuit (Evotec) and Lonza. Direct peers are Recipharm and Cambrex.
Does Kemipharm have an API?
No public API is recorded for Kemipharm.